(Q62030974)
Statements
Impact of Chronic Kidney Disease (CKD) on Pharmacodynamic Profiles of the P2Y12 Receptor Inhibitor Clopidogrel in the Setting of Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD) (English)
0 references
January 2019
0 references
January 2020
0 references
60
0 references
18 year
0 references